Robert T. Langdon Partner MAIN OFFICE: New York Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, N.Y. 10019-6099, U.S.A. T 212-728-8843 F 212-728-9843

---

Robert T. Langdon is a partner in the Corporate and Financial Services Department of Willkie Farr & Gallagher LLP in New York. Mr. Langdon specializes in mergers and acquisitions, private equity and venture capital transactions and public and private securities offerings.

In the areas of private equity and venture capital, Mr. Langdon frequently represents private equity funds, hedge funds and public and private portfolio companies in various transactions, including going-private transactions, stock and asset sales, venture capital financings, PIPEs investments and a wide range of other transactions. Mr. Langdon has represented funds controlled by D.E. Shaw, Third Point, Vitruvian Partners, Warburg Pincus and others.

Mr. Langdon also represents financial advisory and investment banking firms in leveraged buyouts, business combinations, divestitures, securities offerings and other types of transactions.

Mergers and Acquisitions. Mr. Langdon represented:

• MLM Information Services and Warburg Pincus in connection with Warburg Pincus’ sale of MLM to the parent company of Corporation Service Company
  
  
• Tinopolis Group in connection with its acquisitions of A. Smith & Co. Productions and BASE Productions
  
  
• Warburg Pincus in connection with the acquisition of ZymoGenetics, Inc. by Bristol-Myers Squibb Company
  
  
• Warburg Pincus in connection with its leveraged buyout (with Silver Lake) of Interactive Data Corporation
  
  
• Warburg Pincus in connection with the sale of Metavante Technologies, Inc. to Fidelity National Information Services, Inc. 
  
  
• A Special Committee of the Board of Mediacom Communications in Mediacom’s repurchase of stock from a significant stockholder in a tax-free split off.
  
  
• Petro Stopping Centers in connection with its sale to TravelCenters of America and Hospitality Properties Trust.
  
  
• Warburg Pincus in connection with its leveraged buy-out of ARAMARK Corporation.
  
  
• Forest City Ratner Company in connection with its restructuring of 30 retail, office and residential operating properties and certain service companies that were jointly owned by Forest City Enterprises and Bruce Ratner.
  
  
• Warburg Pincus in connection with its acquisition of Wall Street Systems.
  
  
• Wall Street Systems in connection with several acquisitions and its sale to ION Trading.
  
  
• Warburg Pincus in connection with the sale of Transkaryotic Therapies, Inc. to Shire Pharmaceuticals Group plc.
  
  
• A Special Committee of the Board of The Titan Corporation in connection with its proposed merger with Lockheed Martin.
  
  
• Warburg Pincus in connection with its leveraged buy-out of Polypore.
  
  
• Neuberger Berman in connection with its sale to Lehman Brothers.

Private Equity and Venture Capital. Mr. Langdon represented:

• Warburg Pincus in connection with its investments in Benchmark Solutions, Constitution Medical Investors, Cranite Systems, eCert, ev3, Hana Biosciences Inc., Home Dialysis Plus, InterMune, Lutonix, Micro Therapeutics, Mission Motors, MLM Information Services, Nuance Communications, Protox Therapeutics, RegionalCare Hospital Partners, Silk Road Medical, Spigit, WuXi PharmaTech, and several other companies.
  
  
• A consortium of investors, including Conti Street Minerals and the LeFrak organization, in connection with the purchase of convertible preferred units of Black Stone Minerals Company, L.P.
  
  
• Third Point in connection with its PIPEs investment in Exco Resources.
  
  
• Duquesne Capital Management in connection with its PIPEs investment in Gentium S.p.a.
  
  
• D.E. Shaw in connection with its purchase of second-lien convertible notes from RCN Corporation in connection with RCN’s emergence from Chapter 11.

Financial Advisor and Investment Banking Representations. Mr. Langdon represented:

• Deutsche Bank in several transactions, including the acquisition of Quintana Maritime Limited by Excel Maritime Carriers Ltd., the sale of Packaging Dynamics to a portfolio company owned by Kohlberg & Company and the sale of InVision Technologies to General Electric.
  
  
• Peter J. Solomon in several transactions, including the acquisition of Guitar Centers by Bain Capital and the acquisition of Option Care by Walgreens.
  
  
• The Blackstone Group as financial advisor to Central Parking in connection with its sale to Kohlberg & Company and other investors.
  
  
• Piper Jaffray and Banc of America Securities in ev3’s initial public offering.